🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.760
-0.060 (-2.13%)
At close: Nov 19, 2026, 4:00 PM EST
2.630
-0.130 (-4.71%)
After-hours: Nov 19, 2026, 6:19 PM EST

OnKure Therapeutics Statistics

Total Valuation

OKUR has a market cap or net worth of $111.79 million. The enterprise value is -$50.73 million.

Market Cap111.79M
Enterprise Value -50.73M

Important Dates

The last earnings date was Wednesday, November 4, 2026, after market close.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

OKUR has 40.50 million shares outstanding. The number of shares has increased by 139.12% in one year.

Current Share Class 40.50M
Shares Outstanding 40.50M
Shares Change (YoY) +139.12%
Shares Change (QoQ) +0.12%
Owned by Insiders (%) 10.22%
Owned by Institutions (%) 49.26%
Float 17.88M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 111.79
PB Ratio 0.71
P/TBV Ratio 0.71
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.84, with a Debt / Equity ratio of 0.01.

Current Ratio 18.84
Quick Ratio 18.58
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -10,998.33

Financial Efficiency

Return on equity (ROE) is -55.18% and return on invested capital (ROIC) is -36.56%.

Return on Equity (ROE) -55.18%
Return on Assets (ROA) -34.38%
Return on Invested Capital (ROIC) -36.56%
Return on Capital Employed (ROCE) -41.69%
Weighted Average Cost of Capital (WACC) 8.22%
Revenue Per Employee n/a
Profits Per Employee -$1.37M
Employee Count45
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -5.80% in the last 52 weeks. The beta is 0.73, so OKUR's price volatility has been lower than the market average.

Beta (5Y) 0.73
52-Week Price Change -5.80%
50-Day Moving Average 2.68
200-Day Moving Average 3.61
Relative Strength Index (RSI) 50.24
Average Volume (20 Days) 400,685

Short Selling Information

The latest short interest is 1.30 million, so 3.20% of the outstanding shares have been sold short.

Short Interest 1.30M
Short Previous Month 1.39M
Short % of Shares Out 3.20%
Short % of Float 7.26%
Short Ratio (days to cover) 2.89

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -65.99M
Pretax Income -61.85M
Net Income -61.85M
EBITDA -65.64M
EBIT -65.99M
Earnings Per Share (EPS) -$1.94
Full Income Statement

Balance Sheet

The company has $163.31 million in cash and $790,000 in debt, with a net cash position of $162.52 million or $4.01 per share.

Cash & Cash Equivalents 163.31M
Total Debt 790,000
Net Cash 162.52M
Net Cash Per Share $4.01
Equity (Book Value) 157.74M
Book Value Per Share 3.89
Working Capital 156.80M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$47.89 million and capital expenditures -$49,000, giving a free cash flow of -$47.94 million.

Operating Cash Flow -47.89M
Capital Expenditures -49,000
Depreciation & Amortization 348,000
Net Borrowing n/a
Free Cash Flow -47.94M
FCF Per Share -$1.18
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OKUR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -139.12%
Shareholder Yield -139.12%
Earnings Yield -70.32%
FCF Yield -42.88%

Analyst Forecast

The average price target for OKUR is $15.25, which is 452.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.25
Price Target Difference 452.54%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2